As of May 3, 2024, the Innoviva stock's PE ratio is 5.53. This takes into account the latest EPS of $2.75 and stock price of $15.2. The PE ratio has decreased by 24% from its last 4 quarters average of 7.3.
The PE ratio of Innoviva has averaged 10.45 over the last eight years. The current price-to-earnings ratio of 5.53 is 47% less than the historical average. Analyzing the last eight years, INVA's PE ratio reached its highest point in the Jun 2016 quarter at 61.94, when the price was $10.53 and the EPS was $0.17. The lowest point was recorded in the Sep 2022 quarter, when it reached 2.68 with a price of $11.61 and an EPS of $4.33.
Maximum annual increase: 105.39% in 2019
Maximum annual decrease: -60.79% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 5.83 | 34.95% |
| 2022 | 4.32 | -18.8% |
| 2021 | 5.32 | -5.17% |
| 2020 | 5.61 | -38.62% |
| 2019 | 9.14 | 105.39% |
| 2018 | 4.45 | -60.79% |
| 2017 | 11.35 | -42.71% |
| 2016 | 19.81 | N/A |
| 2015 | N/A | N/A |
| 2014 | N/A | N/A |
The current PE ratio of INVA is under its 3, 5 and 10-year averages.
When compared to its peer stock ORGO, INVA's PE ratio is lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| INVA Innoviva Inc | 5.53 | $961.06M |
| ORGO Organogenesis Holdings Inc | 62.25 | $328.59M |
| OPTN OptiNose Inc | N/A | $113.78M |
| OPK Opko Health Inc | N/A | $906.09M |
As of May 3, 2024, INVA stock has a price to earnings ratio of 5.53.
The 3-year average PE ratio for INVA stock is 6.18.
The 5-year average PE ratio for INVA stock is 5.87.
Over the last eight years, the quarterly PE ratio reached its highest level at 61.94 in the Jun 2016 quarter.
INVA's price to earnings ratio is currently 47% below its 8-year historical average.
INVA's PE ratio of 5.53 is considered low because the company's stock price is trading at a lower multiple of earnings.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (May 3, 2024), Innoviva's share price is $15.2. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $2.75. Therefore, Innoviva's price to earnings ratio for today is 5.53. PE RATIO(5.53) = STOCK PRICE($15.2) / TTM EPS($2.75)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.